Cambridge Cognition (Group)

https://www.cambridgecognition.com

Cambridge Cognition is a technology company developing digital health products to better understand, detect and treat conditions affecting brain health. The Company’s software products assess cognitive health in patients worldwide to improve clinical trial outcomes, identify and stratify patients early and improve global efficiency in pharmaceutical and healthcare industries. *

	Start	2021-04-22 existent
	Industry	digital health (healthcare informatics)
	Person	Stork, Matthew (Cambridge Cognition 202107 CEO)

	Region	Cambridge, Cambridgeshire
	Country	United Kingdom (GB)
	City	n. a. Cambridge, Cambridgeshire
		Address record changed: 2021-08-12

Basic data	Employees	n. a.

		* Document for »About Section«: Monument Therapeutics Ltd.. (7/1/21). "Press Release: Digital Brain Biomarker Company Monument Therapeutics Raises £2.6 Million". Manchester.

		Record changed: 2022-01-02

Picture Berlin Partner Voices Robinson Data for Precision Medicine 650x200px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)